Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nippi Collagen NA is the North American subsidiary of Nippi, Inc., a global leader in collagen research and production headquartered in Japan. The company specializes in providing high-purity collagen ingredients, including atelocollagen and collagen peptides, for the pharmaceutical, medical device, nutraceutical, and cosmetic industries. Nippi is historically significant for being the first to successfully solubilize collagen, a breakthrough that expanded its use in medical and research applications. Their products are widely utilized in regenerative medicine, tissue engineering, and as premium ingredients in dietary supplements for joint and skin health. The company maintains rigorous quality standards, offering both bovine and marine-derived collagen solutions backed by extensive scientific research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nippi Collagen NA.